Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 342.00
Bid: 340.50
Ask: 342.00
Change: -3.00 (-0.87%)
Spread: 1.50 (0.441%)
Open: 348.00
High: 354.00
Low: 341.50
Prev. Close: 345.00
VLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

12 Feb 2013 07:00

RNS Number : 6408X
Volex PLC
12 February 2013
 



12 February 2013

VOLEX plc

 

Interim Management Statement

Volex plc ('Volex' or the 'Group), the global provider of electrical, digital and optical connections, today releases its second Interim Management Statement for FY2013, covering the 19 weeks to 11 February 2013.

Group trading

Trading conditions have remained challenging, as previously reported in our 14 December 2012 update. Despite the background of macro-uncertainty and general softening of demand, we have won new business with a major global technology company. We are making good progress with our restructuring programme. Our sales and finance functions have been strengthened and are more closely aligned with our sectors. Production cost and operating expense savings are being delivered as expected. Accordingly, management expects full year revenue and operating profit* for the year ending 31 March 2013 to be in line with revised market expectations**.

Update on improvement plan

Management is focused on a number of initiatives to improve performance and consequently rebuild shareholder value. These include strengthening the senior sales leadership team and the effectiveness of our sales organisation, executing our cost reduction initiatives and accelerating the Group's move to a higher margin product portfolio. While there is still much to do we have made good progress.

Daniel Abrams joined the Company, as Chief Financial Officer on 17 December 2012. We have reorganised the sales and finance functions to better serve key accounts, improve alignment with our sectors, and strengthen our forecasting processes. We have also appointed Roger Wendelken as Senior Vice President, Sales and Marketing. Most recently Roger was SVP Worldwide Sales at SMSC prior to its acquisition by Microchip and he has also held senior sales roles at Applied Micro Circuits Corporation (AMCC), Marvell Semiconductors and IBM.

We are on track to deliver the targeted cost savings of an annualised $10m. We have also increased production efficiency and lowered scrap rates.

On 14 January 2013, the Company successfully completed the acquisition of the active optical technology platform from Applied Micro Circuits Corporation, based in California. The acquisition of a patent portfolio, technology and product designs for active optical cable (AOC) assemblies provides Volex with accelerated entry into the multi-billion dollar AOC and optical transceiver market. It represents a modest yet important step towards developing new technological capabilities to drive higher margin revenue growth.

Financial position

Net debt at 31 December 2012 was $14.8m (31 March 2012: net cash $3.6m).

 

 

Outlook

Trading conditions have remained challenging in the early part of 2013. Management expects full year revenue and operating profit* for the year ending 31 March 2013 to be in line with revised market expectations**.

- END -

Notes

* Operating profit is defined as normalised operating profit before exceptional restructuring costs and share based payment charges

** The average of analyst forecasts, updated since the trading update on 14 December 2012, is $473m in revenue and $11m in operating profit for the year ending 31 March 2013.

For further information please contact:

 

Volex plc

Ray Walsh Chief Executive Officer +44 20 3370 8830

Daniel Abrams Chief Financial Officer +44 20 3370 8830

Tulchan Communications

Christian Cowley / James Macey White +44 207 353 4200

 

 

Forward looking statements

Certain statements in this announcement are forward-looking statements which are based on Volex's expectations, intentions and projections regarding its future operating performance and objectives, anticipated events or trends and other matters that are not historical facts. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words as 'anticipates', 'aims', 'could', 'may', 'should', 'expects', 'believes', 'intends', 'plans', 'targets', 'goal' or 'estimates'. By their very nature forward-looking statements are inherently unpredictable, speculative and involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, by way of example only and not limited to, general economic conditions, currency fluctuations, competitive factors, the loss or failure of one or more major customers, changes in raw materials or labour costs, and issues associated with implementing our strategic plan among other risks. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, Volex undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMGMZNMNGFZM
Date   Source Headline
3rd Oct 20083:56 pmRNSHolding(s) in Company
3rd Oct 20083:20 pmRNSBlocklisting Interim Review
3rd Oct 20083:14 pmRNSBlocklisting Interim Review
22nd Sep 20087:00 amRNSStrategic Review and Trading Update
13th Aug 20081:05 pmRNSAnnual Information Update
6th Aug 20083:52 pmRNSHolding(s) in Company
6th Aug 20083:46 pmRNSHolding(s) in Company
6th Aug 200811:13 amRNSHolding(s) in Company
24th Jul 200812:05 pmRNSResult of AGM
23rd Jul 20087:00 amRNSAGM & Interim Management Stat
11th Jul 20083:23 pmRNSDirector/PDMR Shareholding
11th Jul 20083:21 pmRNSDirector/PDMR Shareholding
11th Jul 20083:19 pmRNSDirector/PDMR Shareholding
2nd Jul 200811:02 amRNSHolding(s) in Company
9th Jun 20087:00 amRNSFinal Results
28th May 200810:16 amRNSNotice of Results
27th May 20087:00 amRNSDirectorate Change
1st May 20089:50 amRNSHolding(s) in Company
18th Apr 20081:00 pmRNSHolding(s) in Company
17th Apr 20084:29 pmRNSHolding(s) in Company
10th Apr 200811:53 amRNSBlocklisting Interim Review
10th Apr 200811:40 amRNSBlocklisting Interim Review
1st Apr 200812:09 pmRNSHolding(s) in Company
13th Mar 200811:42 amRNSHolding(s) in Company
10th Mar 20087:44 amRNSTrading Statement
3rd Mar 20089:48 amRNSHolding(s) in Company
18th Feb 20083:09 pmRNSDirector/PDMR Shareholding
15th Feb 20087:00 amRNSInterim Management Statement
1st Feb 20083:12 pmRNSHolding(s) in Company
29th Jan 20083:59 pmRNSTrading Update
24th Jan 200812:57 pmRNSDirectorate Change
23rd Jan 20085:02 pmRNSDirectorate Change
10th Jan 200812:30 pmRNSDirectorate Change
19th Dec 20073:26 pmRNSHolding(s) in Company
6th Dec 200711:16 amRNSHolding(s) in Company
12th Nov 20077:00 amRNSInterim Results
1st Nov 20073:36 pmRNSHolding(s) in Company
31st Oct 20071:51 pmRNSHolding(s) in Company
17th Oct 20074:49 pmRNSBlocklisting Interim Review
17th Oct 20074:48 pmRNSBlocklisting Interim Review
17th Oct 20074:48 pmRNSBlocklisting Interim Review
5th Oct 200712:10 pmRNSHolding(s) in Company
26th Sep 20073:25 pmRNSDirector/PDMR Shareholding
24th Sep 20079:41 amRNSHolding(s) in Company
24th Sep 20079:24 amRNSNotice of Results
28th Aug 200711:27 amRNSHolding(s) in Company
17th Aug 20073:12 pmRNSHolding(s) in Company
13th Aug 200711:03 amRNSAnnual Information Update
2nd Aug 200710:22 amRNSDirector/PDMR Shareholding
24th Jul 20074:29 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.